Switz Capital is excited to lead an investment in LIGHTYX, a groundbreaking early stage business transforming construction layout by displaying digital plans using cutting-edge laser technology. With unmatched accuracy, LightYX provides contractors with a cost-effective solution to boost productivity, reduce rework and enhance quality of work. To learn more, visit https://www.lightyx.com/ or contact Alex Josowitz for additional information!
Switz Venture Group
Business Consulting and Services
Timonium, MD 41 followers
Switz Advisory and Switz Capital
About us
Switz Advisory and Switz Capital Led by Alex Josowitz, a highly accomplished CEO, board member, consultant, and investor with a successful track record of building companies > 50X from startup to market leadership. Switz Advisory provides strategic consulting services to growth companies, institutional investors, and founders looking to rapidly scale businesses, professionalize operations, or develop a comprehensive business exit strategy. Switz Capital is the Angel Investment arm of Switz Venture Group providing funding for startup and high-growth potential businesses looking for a highly-engaged, strategic investment group who has "been there" to collaboratively guide businesses to rapid growth and successful outcomes. For more information, please contact [email protected].
- Industry
- Business Consulting and Services
- Company size
- 2-10 employees
- Headquarters
- Timonium, MD
- Type
- Privately Held
- Founded
- 2023
Locations
-
Primary
Get directions
Timonium, MD 21093, US
Employees at Switz Venture Group
Updates
-
Alex Josowitz is moderating this fantastic panel on Tuesday. Looking forward to connecting with existing friends and colleagues and meeting new!
This Tuesday, Unlock the Secrets to Entrepreneurial Success! 🔐 Immerse yourself in the world of entrepreneurship with Exited Founders at our exclusive Fireside Panel, an #UpRiseMasterclass on March 19, 4:00-6:00 pm. Get to know our panelists! Swipe to learn about the impressive background of Ethel Rubin, Alex J., Luke Cooper, and Christopher (Chris) Brandt - and why their expertise is what your startup needs to supercharge its success! ⚡️↗️ Hear firsthand experiences on the exit process, uncover key factors behind a successful exit strategy, learn from challenges faced and specific mistakes, and gain wisdom on building and scaling a dream team! 📈🚀 Then, afterward from 6:00-8:00pm, the panel will be followed by a special #EquitechTuesday networking event held at Loyola University Maryland's McGuire Hall in celebration of the #Baltipreneurs Demo Day! 🫱🏽🫲🏼🍺 RSVP to both events using the linked in the comments so you don't miss this chance to connect, learn, and be inspired! 💡 Join #UpRise in igniting the spark of success in Baltimore together #ThisIsEquitech
-
-
Unlock the Entrepreneurial Success Blueprint! Immerse yourself in the world of entrepreneurship with Exited Founders at our exclusive Fireside Panel, an #UpRiseMasterclass on March 19, 4:00-6:00 pm. 🦻🏾 Hear firsthand experiences on the exit process, from spark to sealing the deal. 🔐 Uncover key factors behind a successful exit strategy. 🩹 Discover battle scars of entrepreneurship – challenges faced and lessons learned. 🚧 Learn from specific mistakes turned into stepping stones towards success. 🧠 Gain wisdom on building and scaling a dream team, hiring, and retaining top talent. Who are the panelists? 🤔 🔬 Dr. Ethel Rubin: Leads NIH SEED life sciences, delivers value, connects 200+ companies annually, guides assets from development. 📈 Alex J.: Switz Advisory CEO, Switz Capital Angel Investor, drives startups, offers strategic funding and guidance. 📊 Luke Cooper: Latimer Ventures' Founding Partner, focuses on Black & Hispanic Founders, successfully exited enterprise founder. 🖇 Christopher (Chris) Brandt: Audacious Ventures Capital Founder, socially conscious investments, led Audacious Inquiry's growth, impactful acquisitions, exceptional returns. Don't miss this chance to connect, learn, and be inspired! 💡 Join #UpRise in igniting the spark of success in Baltimore together - followed by a special #EquitechTuesday held at Loyola University Maryland (details to come!) #ThisIsEquitech
UpRise Masterclass: An Exclusive Fireside Panel with Exited Founders!
eventbrite.com
-
Switz Venture Group reposted this
Exciting update from Switz Venture Group PortCo CraniUS. Great work Mike and team!
Breaking Barriers in Drug Delivery! Thrilled to share a glimpse into the future of medicine with CraniUS CEO, Michael Maglin! In an insightful interview hosted by Stephen M. Perry, Kymanox CEO, we explore our innovative drug delivery platform, set to redefine possibilities beyond the blood-brain barrier. Big thanks to Chris Frew of BioBuzz for capturing our journey in a must-read article and to Stephen Perry for steering the conversation toward groundbreaking advancements! Read the full article here: https://lnkd.in/eSxGrRPZ Join us in celebrating the fusion of visionaries pushing the boundaries of medical science! #DrugDelivery #Medicalinnovation #CraniUS #BioBuzz #Kymanox #HealthcareAdvancements #BeyondBoundaries
drug-delivery-brain-cranius-michael-maglin
https://biobuzz.io
-
Exciting update from Switz Venture Group PortCo CraniUS. Great work Mike and team!
Breaking Barriers in Drug Delivery! Thrilled to share a glimpse into the future of medicine with CraniUS CEO, Michael Maglin! In an insightful interview hosted by Stephen M. Perry, Kymanox CEO, we explore our innovative drug delivery platform, set to redefine possibilities beyond the blood-brain barrier. Big thanks to Chris Frew of BioBuzz for capturing our journey in a must-read article and to Stephen Perry for steering the conversation toward groundbreaking advancements! Read the full article here: https://lnkd.in/eSxGrRPZ Join us in celebrating the fusion of visionaries pushing the boundaries of medical science! #DrugDelivery #Medicalinnovation #CraniUS #BioBuzz #Kymanox #HealthcareAdvancements #BeyondBoundaries
drug-delivery-brain-cranius-michael-maglin
https://biobuzz.io